Skip to main content

nl
fr
en
de

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Human medicines
Medicines
Medicines
Marketing Authorisation procedures
Procedures

Procedures

Under construction. See other languages.

Last updated on 22/03/2016

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

10/02/2020

Unavailable medicines: new legislative measures

04/02/2020

Jean-Michel Dogné, pharmacovigilance expert at the FAMHP, is appointed member of the World Health Organization's Global Advisory Committee on Vaccine Safety

23/01/2020

Survey on the use of benzodiazepines and related substances for sleep disorders in Belgium

23/01/2020

Clamoxyl I.V.-I.M. available again but discontinuation of its marketing is scheduled for the end of 2021

All news

© 2016 - FAMHP

Site map
Disclaimer